Companies / Rani
Rani
United States
Rani Therapeutics is developing technology to enable orally administered biologics and drugs
Rani, based in United States, has 2 investors on file, among them GV and Samsara BioCapital. Its site was last checked 14 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from GV
536 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (31%), AI & Machine Learning (19%), Enterprise Software (16%).
More from Samsara BioCapital
37 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Samsara BioCapital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Rani and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when GV adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/ranitherapeutics.com/investors
# also
GET /v1/companies/ranitherapeutics.com
GET /v1/companies/ranitherapeutics.com/news